Estimation of plasma afamin levels in patients with periodontitis and Type II diabetes mellitus: A clinico-biochemical study

牙周炎合并II型糖尿病患者血浆阿法明水平的评估:一项临床生化研究

阅读:1

Abstract

INTRODUCTION: Periodontitis is a chronic inflammatory disease, modified by host immune response, where the host-microbial interaction damages proteoglycan, hyaluronan, and collagen, leading to connective tissue breakdown and impaired wound healing due to increased oxidative stress (OS). Afamin (AFM) is a Vitamin E-binding protein that plays a role in antiapoptotic cellular processes related to OS and has been previously associated with the development of insulin resistance (IR). Type II diabetes mellitus (TIIDM) is a major risk factor for periodontitis. The aim of this study was to assess plasma AFM levels in subjects diagnosed with periodontitis, with and without TIIDM. MATERIALS AND METHODS: Seventy-five participants were divided into 3 groups: Group I - 25 healthy controls, Group II - 25 systemically healthy individuals with periodontitis, and Group III - 25 individuals with periodontitis and TIIDM. All periodontal parameters, i.e. plaque index, gingival index, and probing pocket depth, were recorded. Glycemic control in Group III individuals was assessed by glycated hemoglobin (HbA1c) levels. Plasma AFM levels were analyzed using the enzyme-linked immunosorbent assay technique. P < 0.05 was considered to be statistically significant. RESULTS: Mean plasma AFM concentrations in Group I were 30.64 ± 5.88 ng/ml. A significant increase in mean AFM was seen in Group II and III, i.e. 50.76 ± 9.65 ng/ml and 86.44 ± 12.10 ng/ml, respectively. A correlation was seen between deep pockets and increased AFM concentration in both the test groups. It was also found that mean AFM concentrations increased with worsening of glycemic control, i.e. 80.25 ng/ml, 84.25 ng/ml, and 90.92 ng/ml in good, fair, and poor HbA1c control patients, respectively. CONCLUSIONS: Plasma AFM is increased in patients with periodontitis. A higher concentration is seen in patients with periodontitis and TIIDM. OS being the reason for its increase, plasma AFM levels can be used as a marker to identify the incidence of TIIDM in individuals with periodontitis or other inflammatory conditions associated with increased OS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。